In the current trading session, Elevai Labs Inc.’s (ELAB) stock is trading at the price of $0.11, a fall of -59.89% over last night’s close. So, the stock is trading at a price that is -97.35% less than its 52-week high of $4.24 and -48.37% better than its 52-week low of $0.22. Based on the past 30-day period, the stock price is -71.03% below the high and +2.73% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, ELAB’s SMA-200 is $0.7526.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
It is also essential to consider ELAB stock ratios like the price-to-sales ratio, which is 0.95 for the last year.ELAB’s price to book ratio for the most recent quarter was 0.80, resulting in an 23.36 price to cash per share for the period.
How does Elevai Labs Inc. (ELAB) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Elevai Labs Inc. (NASDAQ: ELAB) Ownership Details
I will give a breakdown of the key shareholders in Elevai Labs Inc. (ELAB). Recent figures show that the company’s insiders hold 59.21% of shares. A total of 4 institutional investors hold shares in the company, making 0.75% of its stock and 1.84% of its float.
Jun 30, 2024, it was reported that the Company’s largest institutional holder is Whittier Trust Co. of Nevada, Inc. holding total of 80.67 shares that make 0.39% of the company’s total number of shares and are currently priced at 8695.0.
The securities firm Diversify Advisory Services, LLC holds 52.5 shares of ELAB, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.25%, and the holding percentage of shares is valued at 5659.0.
An overview of Elevai Labs Inc.’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Elevai Labs Inc. (ELAB) traded 5,335,406 shares per day, with a moving average of $0.2934 and price change of -0.1940. With the moving average of $0.3490 and a price change of -0.3914, about 2,923,640 shares changed hands on average over the past 50 days. Finally, ELAB’s 100-day average volume is 1,549,105 shares, alongside a moving average of $0.4870 and a price change of -0.5877.
